Cargando…
Association of EGFR mutations in second primary lung cancer and HER2 expression in breast cancer survivors
BACKGROUND: The incidence of second primary lung cancer (SPLC) is increasing with longer survival rates from breast cancer. Despite of studies to suggest the mutual exclusivity of epidermal growth factor receptor (EGFR) and human epidermal growth receptor 2 (HER2) in several cancers, the effect of H...
Autores principales: | Jang, Yoon Jung, Kim, Seo Yun, Jung, Hong Kyu, Kim, Hye-Ryoun, Kim, Cheol Hyeon, Lee, Hyo-Rak, Kang, Hye Jin, Yang, Sung Hyun, Seol, Hyesil, Na, Im Il |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799167/ https://www.ncbi.nlm.nih.gov/pubmed/35116370 http://dx.doi.org/10.21037/tcr-21-1235 |
Ejemplares similares
-
Factors that Predict Clinical Benefit of EGFR TKI Therapy in Patients with EGFR Wild-Type Lung Adenocarcinoma
por: Kim, Seo Yun, et al.
Publicado: (2019) -
Altered expression of cellular proliferation, apoptosis and the cell cycle-related genes in lung cancer cells with acquired resistance to EGFR tyrosine kinase inhibitors
por: Lee, Tae-Gul, et al.
Publicado: (2017) -
Prognostic and predictive values of EGFR overexpression and EGFR copy number alteration in HER2-positive breast cancer
por: Lee, H J, et al.
Publicado: (2015) -
Breast cancer stem cells in HER2-negative breast cancer cells contribute to HER2-mediated radioresistance and molecular subtype conversion: clinical implications for serum HER2 in recurrent HER2-negative breast cancer
por: Kim, Yun Gyoung, et al.
Publicado: (2017) -
Development of second primary cancer in Korean breast cancer survivors
por: Jung, Hong Kyu, et al.
Publicado: (2017)